Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter

• Status: Completed
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The hypothesis of the study is to evaluate whether ascorbic acid is able to clear totally implanted central venous catheter

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Sao Paulo
• Treatments: Ascorbic Acid

Criteria

Inclusion Criteria:

• Diagnosis of partial or complete obstruction of the totally implanted central venous catheter;

• No signs of inflammation in the area of the port.

Exclusion Criteria:

• Use of oral anticoagulants or intravenous administration in the last seven days;

• Diagnostic and / or suspected infection in the totally implanted central venous catheter;

• Rupture, displacement or fissure of the totally implanted central venous catheter;

• Presence of thrombosis in the vein where the catheter is inserted.